Show simple item record

Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review

dc.contributor.authorGutiérrez Rojas, Luis 
dc.date.accessioned2023-06-29T10:07:25Z
dc.date.available2023-06-29T10:07:25Z
dc.date.issued2022-06-17
dc.identifier.citationL. Gutiérrez-Rojas, J.J. de la Gándara Martín, L. García Buey et al. Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review .Gastroenterología y Hepatología 46 (2023) 382---396[https://doi.org/10.1016/j.gastrohep.2022.06.001]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/82943
dc.description.sponsorshipUniversidad deGranada/CBUAes_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectHCV infectiones_ES
dc.subjectMental illness es_ES
dc.subjectSchizophrenia es_ES
dc.subjectBipolar disorderes_ES
dc.subjectAntiviralses_ES
dc.titlePatients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature reviewes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1016/j.gastrohep.2022.06.001
dc.type.hasVersionVoRes_ES


Files in this item

[PDF]
Name:
1-s2.0-S0210570522001649-main.pdf
Size:
1.084Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
Except where otherwise noted, this item's license is described as Atribución 4.0 Internacional